Angiodynamics Looks To Overcome Legal Woes, Regain Momentum
This article was originally published in The Gray Sheet
Executive Summary
Angiodynamics' plan to sidestep patent infringement concerns relating to its VenaCure laser system for varicose veins could help boost sales growth and lift the cloud over the firm's stock performance after a poor showing in the first quarter